MARKET

AVTR

AVTR

Avantor
NYSE
25.57
-0.01
-0.04%
After Hours: 25.57 0 0.00% 16:03 03/28 EDT
OPEN
25.68
PREV CLOSE
25.58
HIGH
25.85
LOW
25.52
VOLUME
4.05M
TURNOVER
0
52 WEEK HIGH
26.16
52 WEEK LOW
16.63
MARKET CAP
17.34B
P/E (TTM)
54.02
1D
5D
1M
3M
1Y
5Y
Three Reasons to Retain Avantor (AVTR) Stock in Your Portfolio
NASDAQ · 2d ago
Weekly Report: what happened at AVTR last week (0318-0322)?
Weekly Report · 3d ago
BLCO or AVTR: Which Is the Better Value Stock Right Now?
NASDAQ · 03/21 14:41
Weekly Report: what happened at AVTR last week (0311-0315)?
Weekly Report · 03/18 09:20
Buy Rating on Avantor: Strategic Positioning and Market Underestimation Set Stage for Financial Upswing
Daniel Brennan, an analyst from TD Cowen, maintained the Buy rating on Avantor (AVTR – Research Report). The associated price target is $28.00. The company is expected to benefit from a resurgence in bioproduction growth. Corporate insider sentiment is negative on the stock.
TipRanks · 03/18 04:15
Bio-Techne and Qiagen had the biggest increase in short interest levels last month - Baird
Seeking Alpha · 03/13 18:01
Is Avantor, Inc.'s (NYSE:AVTR) ROE Of 6.1% Concerning?
Avantor, Inc. Has a return on equity of 6.1% and is in the Life Sciences industry. Avantor uses a high amount of debt to increase its returns. It has a lower ROE than the average for its industry. The company generates a profit of $0.06 for every $1 it earns. Return on equity is the rate of earnings per share of a company. It can be calculated by multiplying the return by the number of shares in the company.
Simply Wall St · 03/13 17:04
Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
Goldman Sachs projects the global obesity market to potentially reach $100 billion by 2030. Dominant market players like Eli Lilly and Novo Nordisk are expected to increasingly outsource production of GLP-1 drugs. Goldman Sachs identified a substantial opportunity in the manufacturing sector for new obesity drugs.
Benzinga · 03/13 16:35
More
About AVTR
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies & applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.

Webull offers Avantor Inc stock information, including NYSE: AVTR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVTR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVTR stock methods without spending real money on the virtual paper trading platform.